University of Toledo Department for Human Research Protection and Institutional Review Boards.

Slides:



Advertisements
Similar presentations
The Role of the IRB An Institutional Review Board (IRB) is a review committee established to help protect the rights and welfare of human research subjects.
Advertisements

SOP Melody Lin, Ph.D. Deputy Director, Office for Human Research Protections Director, International Activities Santiago, Chile August.
The Institutional Review Board. What is an IRB? An IRB is committee set up by an institution to review, approve, and regulate research conducted under.
Institutional Review Boards (IRBs), Informed Consent, and Responsibilities Requirement for IRBs -DHHS: 45 CFR Part 46 -FDA: 21 CFR 56 Requirement for and.
Fundamentals of IRB Review. Regulatory Role of the IRB Authority to approve, require modifications in (to secure approval), or disapprove all research.
IRB Determinations 1. AAHRPP Site Visit Results Site visitors observed a real commitment to human subject protections Investigator and research staff.
Evaluating Risk 1 IRB CELT Presentation Colleen Donaldson – IRB Administrator Julie Wilkens – IRB Coordinator.
1 Human Subjects Research at Johns Hopkins Medicine Introduction to Clinical Research Human Subject Protection and IRBs.
Recently Issued OHRP Documents: Guidance on Subject Withdrawal and Draft Revised FWA Secretary’s Advisory Committee on Human Research Protections October.
Conflict and Consent: Managing Disclosure in Human Subjects Research University of Miami Human Subjects Research Office Conflict of Interest Symposium.
Pharmacists Responsibilities in Clinical Studies Mike R Sather, PhD Crystal L Harris, PharmD February 26, 2004.
Research Involving Human Subjects Review of Risk and Protection from Harm.
IRB-Investigator/ Research Coordinator Mtg. “CUMC’s New Progressive Policy For Adverse Event Reporting” April 13, 2004 George Gasparis Andrew Wit, Ph.D.
Columbia University IRB IRB 101 September 21, 2005 George Gasparis, Executive Director, CU IRB Asst. V.P. and Sr. Asst. Dean for Research Ethics.
CUMC IRB Investigator Meeting Human Subjects Research Non-Compliance September 15, 2005.
IRB-Investigator/ Research Coordinator Mtg. “What You Can Do to Facilitate an Efficient IRB Review” January 13, 2004 George Gasparis.
SPS Round Table The Use of Human Participants in Research Office of Research Integrity and Assurance (ORIA) April 17, 2007.
Scientific Data Management for the Protection of Human Subjects Robert R. Downs NASA Socioeconomic Data and Applications Center (SEDAC) Center for International.
Overview of Good Clinical Practices (GCPs)
Federalwide Assurance Presentation for IRB Members.
Human Subjects Overview.
Avoiding the Pitfalls of an IRB Submission Chris Ayres Chair, Institutional Review Board Social & Behavioral Science & Chair, Department of Kinesiology,
International Research & Research Involving Children K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development.
ORO Reviews: Frequent Findings Related to IRBs Bob Brooks Associate Director Research Compliance Education and Policy VHA Office of Research Oversight.
 Understanding the IRB Process University of Tennessee Health Science Center Institutional Review Board.
Brief Introduction to Review of Human Subjects Research in the Health Sciences Presentation to Primary Care Faculty Development Program Nichelle Cobb,
Michelle Groy Johnson Quality Improvement Officer Research Integrity Office Tough Love: Understanding the Purpose and Processes of Quality Assurance.
IRB Electronic Submission. IRB Definition Committee formally designated to approve, monitor, and review biomedical and behavioral research involving human.
Legal & Ethical Issues. Objectives At the completion of this session the participant will be able to: ◦ Describe the ethical principles associated with.
The Institutional Review Board: A Community College Toolkit Dr. Geri J Anderson.
IRB BASICS: Issues in Ethics and Human Subject Protections Prepared by Ed Merrill Department of Psychology November 12, 2009.
Institutional Review Board (IRB) What is our Purpose and Role for Ethical Research.
TERRENCE F. ACKERMAN, PH.D. PROFESSOR OF BIOETHICS CHAIR, UTHSC IRB.
UMBC POLICY ON ESH MANAGEMENT & ENFORCEMENT UMBC Policy #VI
Human Research Protection Program & IRB Responsibilities Marisue Cody, PhD Director Center on Advice & Compliance Help.
11/12/20151 IRBs from Both Sides Now Bennett I. Bertenthal Indiana University.
Institutional Review Board Issues for Classroom Research Sharon McWhorter IRB Administrator, The University of Akron (With assistance from Phil Allen,
Brown Bag Series on Research Faculty Protection of Human Subjects in Research February 10, 2012 Gerberding Hall 142, University of Washington.
Quality Assurance Dr Christopher Stevens
AAHRPP ACCREDITATION (Association for the Accreditation of Human Protection Programs)
APPROVAL CRITERIA AN IRB INFOSHORT MAY CFR CRITERIA FOR IRB APPROVAL OF RESEARCH In order for an IRB to approve a research study, all.
HRPP Policies & Forms Chapter Two Created/Revised for AAHRPP June 1, 2007.
WELCOME to the TULANE UNIVERSITY HUMAN RESEARCH PROTECTION OFFICE WORKSHOP for SOCIAL/BEHAVIORAL RESEARCH (March 2, 2010) Tulane University HRPO Uptown.
2012 State of the IRB Boston University Charles River Campus (CRC) Cynthia J. Monahan, MBA, CIP Director, Institutional Review Board.
Conflicts of Interest in Research : Perspective of the IRB Human Subject Protections Monika S. Markowitz, PhD Director, Office of Research Compliance and.
Joni Barnard IRB Information Session: EHE Workshop 10/13/2015.
Conducting Research at Lincoln IRB/HRPP Policies, Procedures & Good Clinical Practices B Kanna MD, MPH, FACP Associate Program Director of Internal Medicine.
The TJU Human Research Protection Program (HRPP): Part I – Which Entities/Offices are Involved ? J. Bruce Smith, MD, CIP.
Chapter 5 Ethical Concerns in Research. Historical Perspective on Ethics Nazi Experimentation in WWII –“medical experiments” –Nuremberg War Crime Trials.
Legal Responsibilities for Studies Conducted or Supported by HHS Michael A. Carome, M.D. Associate Director for Regulatory Affairs Office for Human Research.
 What is an IRB and why do we need one at Western?  Who needs to submit proposals to the IRB?  If approved, how long is your proposal good for?  Is.
VA Central IRB K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development Department of Veterans Affairs.
Marianne M. Elliott Office of Research Integrity and Ethics Bureau of Medicine and Surgery U. S Navy.
SoTL Research and the IRB Process Kathleen McKinney, Cross Chair in SoTL Nancy Latham, Campus IRB Executive Committee Phyllis McCluskey-Titus, SoTL Scholar.
THE INSTITUTIONAL REVIEW BOARD. WHAT IS AN IRB? An IRB is committee set up by an institution to review, approve, and regulate research conducted under.
Quality Metrics of Performance of Research Ethics Committees Cristina E. Torres, PhD FERCAP Coordinator.
Investigator Initiated Research Best Practices for IRB: SBER Corey Zolondek, Ph.D. IRB Operations Manager Wayne State University.
Christine Yalda, J.D., Ph.D. Chair, Human Research Review Committee Grand Valley State University.
GCP (GOOD CLINICAL PRACTISE)
Conditional IRB Approval
IRB BASICS Ethics and Human Subject Protections Summer 2016
University of Central Florida Office of Research & Commercialization
Beverley Alberola, CIP Associate Director, Research Protections
Investigator Responsibilities in Human Subjects Research
Jeffrey M. Cohen, Ph.D. CIP President HRP Associates, Inc.
HUMAN RESEARCH PROTECTION PROGRAM or
IRB BASICS: Ethics and Human Subject Protections
Making Your IRBs and Clinical Investigators HIPAA-Ready
Exploring 45 CFR , Criteria for IRB Approval of Research
Research with Human Subjects
Presentation transcript:

University of Toledo Department for Human Research Protection and Institutional Review Boards

9/11/2007IRBs and DHRP Department for Human Research Protection (DHRP) and Institutional Review Boards (IRBs)  DHRP is UT department that manages the business of the IRBs and Human Subject Research  IRBs are federally mandated bodies required to review all federally funded human research will apply the same ethical and regulatory standards to all research UT Federalwide Assurance states that we will apply the same ethical and regulatory standards to all research at UT, regardless of funding Appointed by Provosts, but function autonomously with respect to approval of research

9/11/2007IRBs and DHRP  Risks to subjects are minimized and are reasonable in relation to anticipated benefits  Informed consent will be sought from each prospective subject or their legally authorized representative (unless waived) and will be appropriately documented prospectively  All Research must be approved prospectively  When appropriate, the research plan makes adequate provision for monitoring the data collected to ensure the safety of subjects and confidentiality of information. Key Aspects of Federal Requirements to Approve Research

9/11/2007IRBs and DHRP University of Toledo Department of Human Research Protection (DHRP) and IRBs VP Research Administration DHRP Director of Operations DHRP Director of Regulatory Compliance Biomed IRB Coordinator UT DHRP Executive Committee Biomedical IRB Chair and Vice Chair SBE IRB Chair and Vice Chair Director of Operations Compliance Director SBE IRB Coordinator Biomedical IRB UT President Department Secretary Other Designated IRBs BGSU IRB #1 SVMMC Pediatric IRB T-CHOP IRB WIRB Social/Behavioral/Educational IRB DHRP

9/11/2007IRBs and DHRP IRB and DHRP Personnel  IRBs SBE Chair - Barbara Chesney, PhD Vice Chair - Lee Pizzimenti, JD BioMed Chair - Roland Skeel, MD Vice Chair - Deepak Malhotra, MD  DHRP Administration Director of Operations - Carolyn Pinkston, RN, BS Director of Regulatory Compliance - Samara Wisniewski, JD

9/11/2007IRBs and DHRP DHRP and IRB Activity  Approximately 1400 human subject research transactions in 2006  Major types of transactions New Projects, full committee review New Projects, expedited review (minimal risk) Amendments (Largest task of Biomedical IRB) Continuing Review, no less often than yearly. (No such thing as extension!)  All require IRB and DHRP staff actions and formal approval letters sent to investigators

9/11/2007IRBs and DHRP Merger Issues - DHRP and IRBs  Accomplished Joined two programs under one administrative structure with one database Appointed new chair and vice chair for SBE IRB and repopulated both boards, including “cross-over” members, e.g., pediatrician on SBE IRB & social scientist on BIOMED IRB Increased rigor, efficiency, and customer friendliness Merged two sets of IRB policies and procedures into one Updated forms on Main Campus in anticipation of Web- based application process Decreased lag time on HSC

9/11/2007IRBs and DHRP Merger Issues - DHRP and IRBs  In Process Recent Launching  Pro-active Audits: Random “Compliance Support Visits”  For Cause Audits Increasing profile of DHRP staff leadership on Main Campus Assuring that processes on both campuses meet federally mandated standards Launch common UT Web-site for all human subject research, with policies, procedures, forms, links.

9/11/2007IRBs and DHRP Compliance Progress Report  Assured adequacy of informed consent document  Working to guard against apparent coercion  Restored community member to SBE board  Insisting upon prospective review of all grad student research  Maintained continuing review schedule according to Federal regulations (< yearly)

9/11/2007IRBs and DHRP DHRP Plans for  Expand University-wide education about Human Subject Research to Deans, Faculty, Administration, Research Staff, and Students  Remedy inadequate staffing on MC (< 1 FTE for administrative support)  Explore accreditation by Association for the Accreditation of Human Research Protection Programs (AAHRPP) Facilities Staff issues  Develop or purchase Web-based human subject IRB research applications and tracking system.

9/11/2007IRBs and DHRP

9/11/2007IRBs and DHRP

9/11/2007IRBs and DHRP

9/11/2007IRBs and DHRP Compliance Problems in Clinical Research That Led to Federal Sanctions  University of Minnesota - Failure to get approval or patient consent (OPRR, CMS, FDA, FBI became involved)  Johns Hopkins - Inadequate literature review, inadequate IRB review  Duke University - Too few staff and boards to provide adequate review and monitoring  University of Pennsylvania - Failure to inform patient of risks, failure to keep FDA updated  Rush University - Improper Medicare Billing in Clinical Trials (Will repay $ 1 M)